Star Equity (NASDAQ:STRR) Posts Quarterly Earnings Results, Beats Estimates By $0.10 EPS

Star Equity (NASDAQ:STRRGet Rating) issued its earnings results on Monday. The company reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.15) by $0.10, MarketWatch Earnings reports. Star Equity had a negative return on equity of 29.99% and a negative net margin of 2.80%. During the same quarter in the prior year, the firm posted ($0.35) EPS.

Shares of STRR opened at $0.77 on Wednesday. The company has a market capitalization of $11.46 million, a PE ratio of -0.96 and a beta of 0.43. The business’s 50 day moving average is $1.02 and its 200 day moving average is $1.63. Star Equity has a 12-month low of $0.72 and a 12-month high of $4.67.

An institutional investor recently bought a new position in Star Equity stock. Virtu Financial LLC bought a new position in Star Equity Holdings, Inc. (NASDAQ:STRRGet Rating) in the fourth quarter, according to the company in its most recent filing with the SEC. The fund bought 13,216 shares of the company’s stock, valued at approximately $34,000. Virtu Financial LLC owned 0.23% of Star Equity as of its most recent filing with the SEC. 60.24% of the stock is owned by hedge funds and other institutional investors.

Star Equity Company Profile (Get Rating)

Star Equity Holdings, Inc provides healthcare solutions in the United States and internationally. It operates through four segments: Diagnostic Services, Diagnostic Imaging, Construction, and Investments. It offers imaging services primarily to cardiologists, internal medicine physicians, and family practice doctors; and imaging systems, including nuclear cardiac and general purpose nuclear imaging systems to physician offices and hospitals.

Featured Articles

Earnings History for Star Equity (NASDAQ:STRR)

Receive News & Ratings for Star Equity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Star Equity and related companies with MarketBeat.com's FREE daily email newsletter.